Balyasny Asset Management LLC Charles River Laboratories International, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $1.55 Million - $2.02 Million	-7,503 Reduced 77.37%	2,194 $453,000
Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $64,719 - $86,950	318 Added 3.39%	9,697 $2.63 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $9.9 Million - $14.4 Million	-60,205 Reduced 86.52%	9,379 $2.22 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $8.28 Million - $9.27 Million	42,594 Added 157.81%	69,584 $13.6 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $1.2 Million - $1.37 Million	6,519 Added 31.85%	26,990 $5.67 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $9.45 Million - $12.8 Million	-49,224 Reduced 70.63%	20,471 $4.13 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $13.7 Million - $17.4 Million	69,695 New	69,695 $15.2 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $275,167 - $407,635	1,348 New	1,348 $288,000
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $2.61 Million - $3.69 Million	-10,197 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $3.58 Million - $4.58 Million	10,197 New	10,197 $3.84 Million
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $2.97 Million - $3.6 Million	-23,539 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $7.79 Million - $8.95 Million	-62,311 Reduced 72.58%	23,539 $3.12 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $10.2 Million - $12.3 Million	82,639 Added 2573.62%	85,850 $12.2 Million
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $392,446 - $549,357	-3,744 Reduced 53.83%	3,211 $466,000
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $730,900 - $954,434	6,955 New	6,955 $787,000
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $242,381 - $290,875	-2,162 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $221,323 - $253,494	2,162 New	2,162 $243,000
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $314,208 - $368,640	-3,200 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $123,328 - $145,014	1,228 Added 62.27%	3,200 $350,000
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $190,731 - $215,460	1,972	1,972 $213,000

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.14 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$947 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$696 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$396 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$361 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.47B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account